Patents by Inventor Alex DORENBAUM

Alex DORENBAUM has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF PPAR-DELTA AGONISTS IN THE TREATMENT OF MITOCHONDRIAL MYOPATHY
    Publication number: 20220117972
    Abstract: Described herein is the use of PPAR? agonists in the treatment of mitochondrial myopathy. In one aspect, described herein are methods for treating a primary mitochondrial myopathy (PMM) in a mammal comprising administering to the mammal with a primary mitochondrial myopathy a peroxisome proliferator-activated receptor delta (PPAR?) agonist compound. In another aspect, described herein is a method of modulating PPAR? in a mammal with primary mitochondrial myopathy comprising administering to the mammal with primary mitochondrial myopathy PPAR? agonist compound.
    Type: Application
    Filed: February 20, 2020
    Publication date: April 21, 2022
    Inventors: Colin O'CARROLL, Niall O'DONNELL, Lynn PURKINS, Alex DORENBAUM
  • USE OF A PPAR-DELTA AGONIST IN THE TREATMENT OF FATTY ACID OXIDATION DISORDERS (FAOD)
    Publication number: 20220023306
    Abstract: Described herein is the use of PPAR? agonists in the treatment of fatty acid oxidation disorders.
    Type: Application
    Filed: February 3, 2020
    Publication date: January 27, 2022
    Inventors: Colin O'CARROLL, Niall O'DONNELL, Lynn PURKINS, Alex DORENBAUM